Responding to the challenge of untreatable gonorrhea: ETX0914, a first-in-class agent with a distinct mechanism-of-action against bacterial Type II topoisomerases.
Basarab GS, Kern GH, McNulty J, Mueller JP, Lawrence K, Vishwanathan K, Alm RA, Barvian K, Doig P, Galullo V, Gardner H, Gowravaram M, Huband M, Kimzey A, Morningstar M, Kutschke A, Lahiri SD, Perros M, Singh R, Schuck VJ, Tommasi R, Walkup G, Newman JV.
Basarab GS, et al. Among authors: gowravaram m.
Sci Rep. 2015 Jul 14;5:11827. doi: 10.1038/srep11827.
Sci Rep. 2015.
PMID: 26168713
Free PMC article.
Clinical Trial.